Select Investigative Panel Recommends Contempt for StemExpress
Washington, DC — The Select Investigative Panel today approved a report recommending that StemExpress and its Chief Executive Officer, Catherine Spears Dyer, be held in contempt of Congress for failing to comply with lawfully issued subpoenas. Chairman Marsha Blackburn issued the following statement after the Panel passed the report by a vote of 8-0:
“Nearly one year ago our Panel was established and given the important task of investigating very disturbing allegations that some abortion clinics and middleman procurement organizations, including StemExpresss, were violating federal law by profiting from the sale of human fetal tissue. In order to determine if these entities were in violation of federal law or if the relevant statute needs to be updated, our Panel must review all accounting and banking records.
“Nine months is enough time for an entity to produce accounting documents. It is our hope that by approving this report today, StemExpress and its CEO, Cate Dyer, will begin to take our investigation seriously. It’s time for them to turn over the records we need to complete our investigation.
“A subpoena is not a suggestion. It is a lawful order that must be complied with. If StemExpress continues to obstruct, then we will work with House leadership to determine the necessary next steps.”
A copy of the Contempt Report can be found HERE.